Koers Kazia Therapeutics Australian S.E.
Aandelen
KZA
AU000000KZA9
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 10K 6,53K 6,11K | Omzet 2023 | 555 362,53 338,99 | Marktkapitalisatie | 39,72 mln. 25,94 mln. 24,26 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -24 mln. -15,68 mln. -14,66 mln. | Nettowinst (verlies) 2023 | -20 mln. -13,06 mln. -12,22 mln. | EV/omzet 2022 | 7.714 x |
Nettoliquiditeiten 2022 | 7,36 mln. 4,81 mln. 4,5 mln. | Nettoliquiditeiten 2023 | 3,44 mln. 2,25 mln. 2,1 mln. | EV/omzet 2023 | 65.355 x |
K/w-verhouding 2022 |
-3,27
x | K/w-verhouding 2023 |
-1,55
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,6% |
Recentste transcriptie over Kazia Therapeutics
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+8,57% | 41,34 mld. | |
+49,22% | 41,61 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |